Triomics raises $15M Series A for cancer clinical trials matching automation nextdigitalhealth.com

Triomics raises $15M Series A for cancer clinical trials matching automation

In the fight against cancer, clinical trials and the ability to receive advanced treatments can provide hope for patients. However, despite the multitude of trials conducted annually in the United States, only a small fraction of eligible patients, ranging from 3% to 5%, actually enroll in these trials. The primary bottleneck lies in the cumbersome process of matching patients with appropriate trials, exacerbated by the time constraints faced by busy oncologists and nurses.

Triomics, an AI startup, aims to address this critical issue with its groundbreaking technology. Founded by former MIT biotech researcher Sarim Khan and AI scientist Hrituraj Singh, Triomics leverages the power of generative AI and large language models (LLMs) to streamline matching patients with clinical trials. Recognizing the potential of AI in healthcare, Khan and Singh embarked on their mission in 2021, driven by personal experiences and a commitment to improving patient outcomes.

https://nextdigitalhealth.com/funding-news/triomics-raises-15m-series-a-for-cancer-clinical-trials-matching-automation/